Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 25 studies.
Reviews & meta-analyses: 2 · 2014–2026
Showing all 25 studies, sorted by most relevant.
Feng Li, Li-jing Xie, Guo-hua Sun, et al.
Microporous and Mesoporous Materials, 2019
Yao Zhou, Ruguang Ma, S. Candelaria, et al.
Journal of Power Sources, 2016
Shaolong Zhang, Dong Zhai, Tingting Sun, et al.
Applied Catalysis B: Environmental, 2019
Gao Y, Liu D, Zhao Y, et al.
2025
Lithium-sulfur batteries (LSBs), possessing excellent theoretical capacities, advanced theoretical energy densities, low cost, and nontoxicity, are one of the most promising energy storage battery systems. However, some issues, including poor conductivity of elemental S, the "shuttle effect" of high-order lithium polysulfides (LiPSs), and sluggish reaction kinetics, hinder the commercialization of LSBs. To solve these problems, various carbon-based aerogels with developed surface morphology, tunable pores, and electrical conductivity have been examined for immobilizing sulfur, mitigating its volume variation and enhancing its electrochemical kinetics. In this paper, an extensive generalization about the effective preparation methods of carbon-based aerogels comprising the combined method of carbonization with the gelation of precursors and drying processes (ambient pressure drying, freeze-drying, and supercritical drying) is proposed. And we summarize various carbon carbon-based aerogels, mainly including graphene aerogels (Gas) and carbon nanofiber (CNF) and carbon nanotube (CNT) aerogels as cathodes, separators, and interlayers in LSBs. In addition, the mechanism of action of carbon-based aerogels in LSBs is described. Finally, we conclude with an outlook section to provide some insights into the application of carbon-based aerogels in electrochemical energy storage devices. Based on the discussion and proposed recommendations, we provide more approaches on nanomaterials in high-performance liquid or state LSBs with high electrochemical performance in the future.
Abstract licence: CC BY
Beaumet M, Lazinski LM, Maresca M, et al.
2024
- Enzyme Inhibitors
- Melanins
- Resorcinols
Tyrosinases (TYRs) are copper-containing metalloenzymes present in a large diversity of species. In human, hTYR is responsible for pivotal steps in melanogenesis, catalysing the oxidation of l-tyrosine to l-DOPA and further to dopaquinone. While numerous TYR inhibitors have been reported, polyphenolic compounds tend to dominate the literature. However, many of these compounds, particularly monophenols and catechols, have been identified as alternative substrates rather than true inhibitors, given their structural similarity to natural substrates. Resorcinol-containing compounds have emerged as promising candidates to address this challenge, as the meta-dihydroxy moiety in resorcinol demonstrates resistance to TYR-mediated oxidation, while retaining the favourable interactions with copper ions provided by the hydroxy groups. Although their precise mechanism of action remains debated, resorcinol derivatives have yielded some of the most active compounds against isolated mushroom and human TYRs, as well as clinically used dermocosmetic agents like rucinol and thiamidol, which exhibited very promising effects in patients with facial melasma. This review outlines the development of resorcinol-containing TYR inhibitors, categorized by scaffold type, ranging from simple alkyl analogues to intricate synthetic derivatives. Mechanistic insights about the resorcinol-TYR interaction are also presented and debated.
Abstract licence: CC BY
Yao Zhou, S. Candelaria, Qian Liu, et al.
Journal of Materials Chemistry, 2014
Z. Neale, M. Lefler, J. Long, et al.
Nanoscale, 2023
Lihua Shen, Jundan Tang, Meng Li, et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2024
Li S, Liu S, Yan R, et al.
2025
Beigiazaraghbelagh P, Rostamizadeh S, Poursattar Marjani A, et al.
2024
This research presents an innovative approach for synthesizing 2-amino-4H-chromene derivatives, utilizing 30 mg of NS-doped graphene oxide quantum dots (GOQDs) as a catalyst in a one-pot, three-component reaction conducted in ethanol. The NS-doped GOQDs were synthesized using a cost-effective bottom-up method through the condensation of citric acid (CA) with thiourea and the reaction was carried out at 185 $$^{\circ }$$ C, resulting in the elimination of water. The catalytic performance of the synthesized NS-doped GOQDs resulted in high product yields, achieving up to 98% for the 2-amino-4H-chromene derivatives from aromatic aldehydes, malononitrile, resorcinol, $$\beta$$ -naphthol, and dimedone. The reaction showcased rapid completion time (typically < 2 h), low-cost reagents, and easy work-up procedures. In addition, the study integrates experimental and theoretical analyses, including density functional theory (DFT) calculations, to investigate the electronic properties of the synthesized compounds. Calculated HOMO and LUMO energies indicate efficient charge transfer within the molecular structure. The FT-IR spectra of compound 4c were recorded in the range of 4000–500 cm $${^{-1}}$$ , and vibrational frequencies were computed at the B3LYP/6-311+G(d,p) level, correlating well with experimental data. Detailed analyses, including Mep surfaces, Mulliken population analysis, and Natural Bond Orbital (NBO) analysis, provide further insights into the electronic distribution and reactivity of the compounds. Furthermore, comparative $${^1}$$ H and $${^{13}}$$ C NMR analyses of compound 4c reveal strong agreement between computational and experimental findings. This research not only validates the synthetic method but also emphasizes the dual experimental and computational approach in understanding the structural and electronic characteristics of the 4c compound.
Abstract licence: CC BY-NC-ND
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.